Patton Fund Management Inc. Invests $200,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Patton Fund Management Inc. purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 378 shares of the healthcare conglomerate’s stock, valued at approximately $200,000.

Several other large investors have also recently added to or reduced their stakes in the company. Arrowstreet Capital Limited Partnership boosted its holdings in shares of UnitedHealth Group by 1,682.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after purchasing an additional 2,540,538 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in UnitedHealth Group by 214.1% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,648,123 shares of the healthcare conglomerate’s stock worth $832,368,000 after buying an additional 1,123,340 shares during the period. Vanguard Group Inc. increased its position in shares of UnitedHealth Group by 1.0% in the 3rd quarter. Vanguard Group Inc. now owns 82,969,869 shares of the healthcare conglomerate’s stock worth $41,903,103,000 after purchasing an additional 851,994 shares during the last quarter. Nuveen Asset Management LLC boosted its stake in UnitedHealth Group by 5.3% during the 3rd quarter. Nuveen Asset Management LLC now owns 7,276,059 shares of the healthcare conglomerate’s stock valued at $3,674,701,000 after purchasing an additional 367,153 shares during the period. Finally, Bank of Montreal Can raised its position in shares of UnitedHealth Group by 25.3% during the 4th quarter. Bank of Montreal Can now owns 1,808,237 shares of the healthcare conglomerate’s stock worth $982,090,000 after buying an additional 365,031 shares in the last quarter. 86.31% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $617.00 to $627.00 in a report on Monday, April 17th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research report on Monday, April 17th. Cantor Fitzgerald assumed coverage on shares of UnitedHealth Group in a report on Thursday, April 20th. They set an “overweight” rating and a $591.00 target price on the stock. StockNews.com initiated coverage on shares of UnitedHealth Group in a report on Thursday, May 18th. They set a “strong-buy” rating on the stock. Finally, Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, February 28th. Two investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $600.88.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,008 shares of the stock in a transaction on Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the transaction, the executive vice president now directly owns 10,359 shares in the company, valued at approximately $5,019,764.22. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, EVP Erin Mcsweeney sold 1,008 shares of the stock in a transaction on Friday, April 21st. The stock was sold at an average price of $484.58, for a total value of $488,456.64. Following the transaction, the executive vice president now directly owns 10,359 shares in the company, valued at approximately $5,019,764.22. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Andrew Witty sold 6,160 shares of the firm’s stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the transaction, the chief executive officer now owns 86,564 shares in the company, valued at $42,199,084.36. The disclosure for this sale can be found here. Insiders sold a total of 8,852 shares of company stock valued at $4,313,962 in the last quarter. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Down 0.2 %

UNH opened at $479.44 on Wednesday. UnitedHealth Group Incorporated has a twelve month low of $449.70 and a twelve month high of $558.10. The company has a 50-day simple moving average of $489.26 and a 200 day simple moving average of $500.06. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $446.37 billion, a price-to-earnings ratio of 21.92, a P/E/G ratio of 1.39 and a beta of 0.68.

UnitedHealth Group (NYSE:UNH – Get Rating) last posted its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 EPS for the quarter, topping analysts’ consensus estimates of $6.24 by $0.02. The firm had revenue of $91.93 billion during the quarter, compared to analysts’ expectations of $89.77 billion. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. The business’s revenue for the quarter was up 14.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.49 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 24.98 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 21st. Shareholders of record on Monday, March 13th were given a dividend of $1.65 per share. This represents a $6.60 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date was Friday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 30.18%.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.